• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Incyte axes JAK1 inhibitor from pipeline 2 years after PhIII flop crushed hopes

    ENDPTS

    Incyte sinks as itacitinib fails pivotal test in acute GVHD

    FIERCE BIOTECH

    Incyte takes a beating as a key PhIII study flops in latest painful setback

    BUSINESSWIRE

    Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Itacitinib

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.